ライブ

Clinical OMICsASGCT 2026: Timothy Yu Wins Jerry Mendell Award For N-of-1 Therapies Clinical OMICsTargeted Ultrasound Could Offer Alternative to Chronic Pain Medication Thermo FisherNuvation Bio partners with Thermo Fisher for US drug manufacturing - Investing.com Clinical OMICsTNBC Ecotypes Reveal Molecular Signatures Tied to Chemotherapy Response Clinical OMICsCSF Platform Enables Near Real-Time Monitoring of Multiple Biomarkers Endpoints NewsAfter an apparent cure, a gene editing company struggles to repeat the magic Endpoints NewsTakeda to target 4,500 jobs as incoming CEO continues restructuring Clinical OMICsPersonalized DNA Vaccine Shows Immune Activation and Survival Signals in Glioblastoma Trial Clinical OMICsAberrant Splicing Patterns Could Predict Therapy Response in mRCC Clinical OMICsRate of New Late-Stage Breast Cancers Increases FierceBiotechIcon opens early-phase research unit in San Antonio, plus satellite clinics to grow trial capabilities Endpoints NewsValneva to cut up to 15% of jobs as reduced travel hits vaccine demand

Clinical OMICs 2026年5月13日

Aberrant Splicing Patterns Could Predict Therapy Response in mRCC

Transcriptomic analysis of metastatic renal cell carcinoma identified alternative splicing patterns linked to treatment response, potentially enabling improved...

Transcriptomic analysis of metastatic renal cell carcinoma identified alternative splicing patterns linked to treatment response, potentially enabling improved prognostication and future personalized immunotherapy strategies. The post Aberrant Splicing Patterns Could Predict Therapy Response in mRCC appeared first on Inside Precision Medicine .